Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal deadline: April 25, 2024
V Foundation Pediatric Cancer Research Grants
Two mechanisms are available: Translational Awards (for tenure-track faculty) and Scholar Awards (for early career tenure-track faculty). - Internal deadline: May 2, 2024
Pew Scholars Program in the Biomedical Sciences
Purpose: To support young investigators of outstanding promise in science relevant to the advancement of human health. - Internal deadline: May 17, 2024
Macy's Foundation Faculty Scholars
Purpose: To identify and nurture promising educational innovators in medicine and nursing. Scholars will implement new educational innovations at their home institutions and participate in career development activities.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: April 30, 2024
HDFCCC LEAD Conference Travel Grant RFA
The HDFCCC Office of DEIA Gender Equity Committee is offering conference travel grants for women and gender minorities within the Cancer Center to attend LEAD, a conference designed for women in oncology and hematology. The goal of this conference is to empower women leaders in the hematology and oncology space by providing essential clinical updates, career development, and professional networking. The conference will take place September 27-28th in La Jolla, California. - Deadline: April 30, 2024
HDFCCC Clinical Research Staff Project Support RFA
The UCSF Helen Diller Family Comprehensive Cancer Center is requesting applications from Clinical Research staff to support research conference travel or publication fees. - Deadline: May 6, 2024
HDFCCC Community-Engaged Research Pilot Awards
The Cancer Center is offering pilot project awards of $25,000 to support community-engaged cancer research and translation, education, and outreach addressing needs of communities in our 25-county catchment area. - Deadline: June 1, 2024
HDFCCC Global Cancer Program Fellowships
The HDFCCC Global Cancer Program is now seeking applications from early career investigators who are either in the final stages of training or in a junior faculty position.
Foundations/Other Sources
- LOI Deadline: Apr 29, 2024
The Mark Foundation Emerging Leader Awards
Supports innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. - Deadline: May 13, 2024
Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) for Early-Stage Investigator Physicians
Winn CDA is a 2-year program designed to support the career development of early-stage investigator physicians who are underrepresented in medicine (URiM) or who have a demonstrated commitment to increasing diversity in clinical research. (Cancer Center members may reach out to Robbie Díaz at [email protected] to request support with their applications.) - Deadline: May 15, 2024
Laboratory for Genomics Research (LGR) Innovation Award
The Laboratory for Genomics Research (LGR) Innovation Awards program aims to support early-stage technology development projects that could mature into future UC-LGR collaborative projects. Innovation Awards are one-year research grants to support labs at the UCSF and UC Berkeley campuses with an interest in developing highly innovative ideas into early proofs of concept across the field of functional genomics and CRISPR/Cas-based tool development. The goal for these awards is to support the development of novel platform technologies, disease-related model systems, and the application of these to functional genomics screens. The award is open to Faculty or faculty-equivalent status with primary appointments at UC San Francisco and UC Berkeley.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
- Due Apr 22: Administrative Supplements for Contemporary Modifiable Exposures and Cancer Across the Cancer Control Continuum
- Due Apr 29: Administrative Supplements to Understand Effects of Within-Group Heterogeneity on Cancer Control Outcomes in Underrepresented Populations
- Due June 4: Administrative Supplements for Assessing and Enhancing Survivorship Care
- Due Sept 6: NCI Administrative Supplements to Support Cancer Disparity Collaborative Research
To view NCI funding opportunities, search here